Bartlett & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $303K | Hold |
344
| – | – | ﹤0.01% | 413 |
|
|
2023
Q3 | $283K | Hold |
344
| – | – | 0.01% | 405 |
|
|
2023
Q2 | $247K | Hold |
344
| – | – | ﹤0.01% | 426 |
|
|
2023
Q1 | $283K | Hold |
344
| – | – | 0.01% | 347 |
|
|
2022
Q4 | $248K | Hold |
344
| – | – | 0.01% | 353 |
|
|
2022
Q3 | $237K | Hold |
344
| – | – | 0.01% | 352 |
|
|
2022
Q2 | $203K | Hold |
344
| – | – | ﹤0.01% | 371 |
|
|
2022
Q1 | $240K | Hold |
344
| – | – | ﹤0.01% | 366 |
|
|
2021
Q4 | $217K | Hold |
344
| – | – | ﹤0.01% | 382 |
|
|
2021
Q3 | $208K | Sell |
344
-9
| -3% | -$5.44K | ﹤0.01% | 331 |
|
|
2021
Q2 | $197K | Hold |
353
| – | – | ﹤0.01% | 334 |
|
|
2021
Q1 | $167K | Hold |
353
| – | – | ﹤0.01% | 344 |
|
|
2020
Q4 | $171K | Buy |
353
+9
| +3% | +$4.36K | ﹤0.01% | 341 |
|
|
2020
Q3 | $193K | Hold |
344
| – | – | ﹤0.01% | 313 |
|
|
2020
Q2 | $215K | Buy |
344
+135
| +65% | +$84.4K | 0.01% | 303 |
|
|
2020
Q1 | $102K | Buy |
+209
| New | +$102K | ﹤0.01% | 367 |
|
|
2019
Q3 | $58K | Buy |
209
+168
| +410% | +$46.6K | ﹤0.01% | 502 |
|
|
2019
Q2 | $13K | Buy |
41
+1
| +3% | +$317 | ﹤0.01% | 570 |
|
|
2019
Q1 | $16K | Hold |
40
| – | – | ﹤0.01% | 538 |
|
|
2018
Q4 | $15K | Hold |
40
| – | – | ﹤0.01% | 543 |
|
|
2018
Q3 | $16K | Hold |
40
| – | – | ﹤0.01% | 565 |
|
|
2018
Q2 | $14K | Hold |
40
| – | – | ﹤0.01% | 569 |
|
|
2018
Q1 | $14K | Hold |
40
| – | – | ﹤0.01% | 575 |
|
|
2017
Q4 | $15K | Sell |
40
-15
| -27% | -$5.63K | ﹤0.01% | 553 |
|
|
2017
Q3 | $25K | Hold |
55
| – | – | ﹤0.01% | 509 |
|
|
2017
Q2 | $27K | Hold |
55
| – | – | ﹤0.01% | 501 |
|
|
2017
Q1 | $21K | Buy |
+55
| New | +$21K | ﹤0.01% | 534 |
|